Hattingh Inc.

Hattingh Inc., doing business as Prosthetic Care Facility, is a self-certified small disadvantaged business and Subchapter S Corporation that designs, fabricates, and delivers customized artificial limbs and prosthetic devices to the Department of Veterans Affairs as a prime contractor across multiple VISN regions. The company operates entirely in the full-and-open federal market with no set-aside competition; its footprint centers on Veterans Integrated Service Network contracts, chiefly partial small business set-aside work under a $29.4 million VA IDV.

Hattingh Inc. is headquartered in Leesburg, Virginia and specializes in transfemoral and transtibial prosthetic limbs, microprocessor-controlled knees, custom socket replacements, and prosthesis evaluation services. The company's capability portfolio is tightly focused on prosthetic fabrication and fitting for disabled veterans. Recent representative work includes a $96,455.77 delivery order awarded March 9, 2026 by VISN 5 for artificial limbs and related prosthetic services under the $29.4 million multiple-award IDV running through April 2028; a $65,026.72 purchase order from VISN 6 awarded April 1, 2026 for prosthetic devices; and a $19,000 purchase order from the National Heart Lung and Blood Institute (February 2025) for prosthesis evaluation and replacement under a research protocol, the only non-VA customer in the recent award footprint.

Customer concentration is extreme. VISN 5 dominates by potential value with 18 awards totaling $56.7 million, anchored by the $29.4 million IDV. VISN 7 leads by order count with 45 awards but carries only $922 thousand in combined potential value, reflecting small routine purchase orders for individual prosthetic devices. Together, these two VISNs account for 99% of recent awards. VISN 20, VISN 6, and the National Institutes of Health's National Heart Lung and Blood Institute round out the customer set with minimal activity.

Hattingh Inc. operates under two VA IDV vehicles. The primary vehicle is the multiple-award $29.4 million Indefinite Delivery Contract 36C24523D0069, awarded April 10, 2023 by VISN 5 with a partial small business set-aside, running through April 2028 and covering prosthetic fabrication and fitting at six VA medical centers in Maryland, Washington D.C., and West Virginia. Eight task orders valued at $200 thousand have been placed against this IDV. The secondary vehicle is a single-award $1.06 million IDV (VA24517D0209) that ran January–March 2023 for artificial limb procurement; six task orders valued at $166 thousand were issued under this now-expired contract.

Activity has been volatile. The vendor received 10 awards in 2022, declined to 5 in 2023, rebounded to 11 in 2024, then fell to 4 in 2025 and 2 in 2026 year-to-date. The combined potential value across all 75 prime awards is $57.8 million, but only $1.5 million (3%) has been obligated, reflecting the IDV structure where ceiling values far exceed invoiced spend. Recompete exposure is minimal: only one award with a completion date in the next twenty-four months carries a potential value of $65 thousand. The $29.4 million VISN 5 IDV does not expire until April 2028, creating substantial runway for task order placement through the medium term. The vendor holds no subcontracts and operates exclusively as a prime contractor in the prosthetic medical device supply category (NAICS 339113, PSC J067).